title: Agonist pharmacology of neonatal and adult glycine receptor alpha subunits: identification of amino acid residues involved in taurine activation.
abstract: The inhibitory glycine receptor (GlyR) is a pentameric chloride channel protein which mediates postsynaptic inhibition in the mammalian central nervous system. In spinal cord, different GlyR isoforms originate from the sequential expression of developmentally regulated variants of the ligand binding alpha subunit. Here, neonatal alpha 2 and adult alpha 1 subunits are shown to generate GlyRs with distinct agonist activation profiles upon heterologous expression in Xenopus oocytes. Whereas alpha 1 receptors are efficiently gated by beta-alanine and taurine, alpha 2 GlyRs show only a low relative response to these agonists, which also display a reduced sensitivity to inhibition by the glycinergic antagonist strychnine. Construction of an alpha 2/alpha 1 subunit chimera and site-directed mutagenesis of the extracellular region of the alpha 1 sequence identified amino acid positions 111 and 212 as important determinants of taurine activation. Our results indicate the existence of distinct subsites for agonists on alpha 1 and alpha 2 GlyRs and suggest that the ligand binding pocket of these receptor proteins is formed from discontinuous domains of their extracellular region.
authors.affiliation: Abteilung Neurochemie, Max-Planck-Institut für Hirnforschung, Frankfurt am Main, FRG.
authors.forename: V
authors.initials: V
authors.lastname: Schmieden
authors.forename: J
authors.initials: J
authors.lastname: Kuhse
authors.forename: H
authors.initials: H
authors.lastname: Betz
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D018118:Chloride Channels; D004247:DNA / Q000235:genetics; D005998:Glycine / Q000378:metabolism*; D006801:Humans; D007231:Infant, Newborn; D007473:Ion Channels / Q000502:physiology*; D007700:Kinetics; D046911:Macromolecular Substances; D008564:Membrane Potentials / Q000187:drug effects; D008565:Membrane Proteins / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D008954:Models, Biological; D016297:Mutagenesis, Site-Directed; D009865:Oocytes / Q000187:drug effects / Q000502:physiology*; D016133:Polymerase Chain Reaction; D012313:RNA / Q000235:genetics; D018009:Receptors, Glycine; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D013331:Strychnine / Q000494:pharmacology; D013654:Taurine / Q000494:pharmacology*; D014981:Xenopus
chemical_list: D018118:Chloride Channels; D007473:Ion Channels; D046911:Macromolecular Substances; D008565:Membrane Proteins; D018009:Receptors, Glycine; D017981:Receptors, Neurotransmitter; D013654:Taurine; D012313:RNA; D004247:DNA; D013331:Strychnine; D005998:Glycine